Summary
We report a rare case of synchronous bilateral and multifocal ductal carcinoma in situ (DCIS) in a 30-year-old patient operated on for gynecomastia following repeated injections of stanozolol, a non-aromatizable androgen. The familial medical history was negative for breast cancer and work-up of serum hormone levels was normal. The patient underwent a modified radical mastectomy without axilla dissection 6 weeks following the primary procedure and recovered uneventfully. The role of synthetic androgens in the development of male breast neoplasia warrants further scrutiny.
Similar content being viewed by others
References
Armstrong J, Saunders C, Metcalf C, Male breast ductal carcinoma in situANZ J Surg 73: 774–775, 2003
Hittmair AP, Lininger RA, Tavassoli FA, Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma – a preliminary reportCancer 83: 2139–2149, 1998
Okada K, Kajiwara S, Tanaka H, Sakamoto G, Synchronous bilateral noninvasive ductal carcinoma of the male breast: a case reportBreast Cancer 10: 163–166, 2003
Crichlow RW, Carcinoma of the male breastSurg Gynecol Obstet 134: 1011–1019, 1972
Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, Resbeut M, Graic Y, Campana F, Moncho-Bernier V, et al., Male breast cancer: results of the treatments and prognostic factors in 397 casesEur J Cancer 31A: 1960–1964, 1995
Silverstein MJ, Incidence and treatment of ductal carcinoma in situ of the breastEur J Cancer 33: 10–11, 1997
Wellings SR, Jensen HM, On the origin and progression of ductal carcinoma in the human breastJ Natl Cancer Inst 50: 1111–1118, 1973
Sasco AJ, Lowenfels AB, Pasker-de Jong P, Review article: epidemiology of male breast cancer. A meta-analysis of published case–control studies and discussion of selected aetiological factorsInt J Cancer 53: 538–549, 1993
Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M, Lesaunier F, Graic Y, Tortochaux J, Resbeut M, Lesimple T, Gamelin E, Campana F, Reme-Saumon M, Moncho-Bernier V, Cuilliere JC, Marchal C, De Gislain G, N’Guyen TD, Teissier E, Velten M, Ductal carcinoma in situ of the male breast. Analysis of 31 cases Eur J Cancer 33: 35–38, 1997
Cutuli BF, Florentz P, Lacroze M, Dilhuydy JM, Allavena C, De Lafontan B, Resbeut M, Campana F, Graic Y, Tortochaux J, et al., Breast cancer in males: a study of 15 cases of pure ductal carcinoma in situBull Cancer 79: 1045–1053, 1992
Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF, A comparison outcome of male breast cancer with female breast cancer Am J Surg 173: 185–188, 1997
Serra Diaz C, Vizoso F, Lamelas ML, Rodriguez JC, Gonzalez LO, Baltasar A, Medrano J, Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastiaBr J Surg 86: 1190–1197, 1999
Heller KS, Rosen PP, Schottenfeld D, Ashikari R, Kinne DW, Male breast cancer: a clinicopathologic study of 97 casesAnn Surg 188: 60–65, 1978
Appelqvist P, Salmo M, Prognosis in carcinoma of the male breastActa Chir Scand 148: 499–502, 1982
Ciatto S, Iossa A, Bonardi R, Pacini P, Male breast carcinoma: review of a multicenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), ItalyTumori 76: 555–558, 1990
Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, Grassi M, Prognosis of breast cancer in males: an analysis of 170 casesEur J Cancer 30A: 930–935, 1994
Wadie GM, Banever GT, Moriarty KP, Courtney RA, Boyd T, Ductal carcinoma in situ in a 16-year-old adolescent boy with gynecomastia: a case reportJ Pediatr Surg 40: 1349–1353, 2005
Whitney AC,Clark AS, Effects of acute stanozolol treatment on puberty in female ratsBiol Reprod 64: 1460–1465, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Staerkle, R.F., Lenzlinger, P.M., Suter, S.L. et al. Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Res Treat 97, 173–176 (2006). https://doi.org/10.1007/s10549-005-9107-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9107-6